Lack of Clinical Pharmacokinetic Studies to Optimize the Treatment of Neglected Tropical Diseases: A Systematic Review

Pharmacokinetic Interactions for Drugs with a Long Half-Life—Evidence for the Need of Model-Based Analysis

(2015) Elin M. Svensson et al.   AAPS Journal

Population Pharmacokinetics of Benznidazole in Adult Patients with Chagas Disease

(2015) D. Soy et al.   ANTIMICROBIAL AGENTS AND CHEMOTHERAPY

Chagas’ Disease

(2015) Caryn Bern   NEW ENGLAND JOURNAL OF MEDICINE

Enantiospecific Reassessment of the Pharmacokinetics and Pharmacodynamics of Oral Eflornithine against Late-Stage Trypanosoma brucei gambiense Sleeping Sickness

(2014) R. Jansson-Löfmark et al.   ANTIMICROBIAL AGENTS AND CHEMOTHERAPY

Determination of an Optimal Dosing Regimen for Fexinidazole, a Novel Oral Drug for the Treatment of Human African Trypanosomiasis: First-in-Human Studies

(2014) Antoine Tarral et al.   CLINICAL PHARMACOKINETICS

The little we know about the pharmacokinetics and pharmacodynamics of praziquantel (racemate and R-enantiomer)

(2014) P. Olliaro et al.   JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY

Failure of Miltefosine in Visceral Leishmaniasis Is Associated With Low Drug Exposure

(2014) T. P. C. Dorlo et al.   JOURNAL OF INFECTIOUS DISEASES

The Global Burden of Disease Study 2010: Interpretation and Implications for the Neglected Tropical Diseases

(2014) Peter J. Hotez et al.   PLoS Neglected Tropical Diseases

Population Pharmacokinetic Study of Benznidazole in Pediatric Chagas Disease Suggests Efficacy despite Lower Plasma Concentrations than in Adults

(2014) Jaime Altcheh et al.   PLoS Neglected Tropical Diseases

The lack of influence of food and local alcoholic brew on the blood level of Mectizan® (ivermectin)

(2013) Mamoun M. Homeida et al.   ACTA TROPICA

Pharmacokinetics and Absorption of Paromomycin and Gentamicin from Topical Creams Used To Treat Cutaneous Leishmaniasis

(2013) William R. Ravis et al.   ANTIMICROBIAL AGENTS AND CHEMOTHERAPY

A Review of the Pharmacokinetic Implications of Schistosomiasis

(2013) Kyle J. Wilby et al.   CLINICAL PHARMACOKINETICS

LeishMan Recommendations for Treatment of Cutaneous and Mucosal Leishmaniasis in Travelers, 2014

(2013) Johannes Blum et al.   JOURNAL OF TRAVEL MEDICINE

Dapsone and Body Mass Index in Subjects With Multibacillary Leprosy

(2013) Fernanda M. L. Moura et al.   THERAPEUTIC DRUG MONITORING

The drug and vaccine landscape for neglected diseases (2000–11): a systematic assessment

(2013) Belen Pedrique et al.   Lancet Global Health

Optimal Dosing of Miltefosine in Children and Adults with Visceral Leishmaniasis

(2012) Thomas P. C. Dorlo et al.   ANTIMICROBIAL AGENTS AND CHEMOTHERAPY

Translational pharmacokinetic modelling and simulation for the assessment of duration of contraceptive use after treatment with miltefosine

(2012) T. P. C. Dorlo et al.   JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY

Disability-adjusted life years (DALYs) for 291 diseases and injuries in 21 regions, 1990–2010: a systematic analysis for the Global Burden of Disease Study 2010

(2012) Christopher J L Murray et al.   LANCET

Clinical features, diagnosis, and treatment of human African trypanosomiasis (sleeping sickness)

(2012) Peter GE Kennedy   LANCET NEUROLOGY

Safety and pharmacokinetics of a human monoclonal antibody to rabies virus: A randomized, dose-escalation phase 1 study in adults

(2012) Nithya Gogtay et al.   VACCINE

Pharmacokinetics of Oral Sitamaquine Taken with or without Food and Safety and Efficacy for Treatment of Visceral Leishmaniais: A Randomized Study in Bihar, India

(2011) Shyam Sundar et al.   AMERICAN JOURNAL OF TROPICAL MEDICINE AND HYGIENE

Excretion of Moxidectin into Breast Milk and Pharmacokinetics in Healthy Lactating Women

(2011) Joan M. Korth-Bradley et al.   ANTIMICROBIAL AGENTS AND CHEMOTHERAPY

Pharmacokinetics of combined treatment with praziquantel and albendazole in neurocysticercosis

(2011) Hector H. Garcia et al.   BRITISH JOURNAL OF CLINICAL PHARMACOLOGY

Pharmacokinetics of Rifampin and Clarithromycin in Patients Treated for Mycobacterium ulcerans Infection

(2010) J. W. C. Alffenaar et al.   ANTIMICROBIAL AGENTS AND CHEMOTHERAPY

Pharmacometrics 2020

(2010) Jogarao V. S. Gobburu   JOURNAL OF CLINICAL PHARMACOLOGY

The Need for Modeling and Simulation to Design Clinical Investigations in Children

(2010) Pravin R. Jadhav et al.   JOURNAL OF CLINICAL PHARMACOLOGY

Clinical Efficacy and Pharmacokinetics of Antimony in Cutaneous Leishmaniasis Patients Treated With Sodium Stibogluconate

(2010) Iman Y. Zaghloul et al.   JOURNAL OF CLINICAL PHARMACOLOGY

Antimicrobial treatment for early, limited Mycobacterium ulcerans infection: a randomised controlled trial

(2010) Willemien A Nienhuis et al.   LANCET

Paromomycin for the Treatment of Visceral Leishmaniasis in Sudan: A Randomized, Open-Label, Dose-Finding Study

(2010) Ahmed M. Musa et al.   PLoS Neglected Tropical Diseases

Is use of nifurtimox for the treatment of Chagas disease compatible with breast feeding? A population pharmacokinetics analysis

(2009) F. Garcia-Bournissen et al.   ARCHIVES OF DISEASE IN CHILDHOOD

Albendazole and its metabolites in the breast milk of lactating women following a single oral dose of albendazole

(2009) Ahmed M. Abdel-tawab et al.   BRITISH JOURNAL OF CLINICAL PHARMACOLOGY

The Evolving Scope of PLoS Neglected Tropical Diseases

(2009) Peter J. Hotez et al.   PLoS Neglected Tropical Diseases

Pharmacokinetics of Miltefosine in Old World Cutaneous Leishmaniasis Patients

(2008) T. P. C. Dorlo et al.   ANTIMICROBIAL AGENTS AND CHEMOTHERAPY

The Effect of Azithromycin on Ivermectin Pharmacokinetics—A Population Pharmacokinetic Model Analysis

(2008) Ahmed El-Tahtawy et al.   PLoS Neglected Tropical Diseases

Mucosal leishmaniasis

(2007) Valdir Sabbaga Amato et al.   ACTA TROPICA